Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

Canadian Cancer Trials Group IND.204 -- A Phase II Study of PX-866 in Patients with Glioblastoma Multiforme at Time of First Relapse or Progression -- was centrally activated on Thursday, 9 December 2010.